hackint0sh/temp-data huggingface dataset:
protocolSection identificationModule nctId: NCT06312514, orgStudyIdInfo id: STUDY00008615, secondaryIdInfos id: R01NR021170, type: NIH, link: https://reporter.nih.gov/quickSearch/R01NR021170, briefTitle: Lafiya HIV-status Neutral Study - Protocol, statusModule overallStatus: NOT_YET_RECRUITING, startDateStruct date: 2024-04-20, primaryCompletionDateStruct date: 2028-08-29, completionDateStruct date: 2028-08-29, studyFirstPostDateStruct date: 2024-03-15, lastUpdatePostDateStruct date: 2024-03-15, sponsorCollaboratorsModule leadSponsor name: University of Rochester, class: OTHER, collaborators name: National Institute of Nursing Research (NINR), collaborators name: University of Ghana, collaborators name: Yale University, descriptionModule briefSummary: The primary objective of this study is to adapt and evaluate the feasibility of "Lafiya," which means "Wellness" in Hausa, a multilevel intersectional stigma \& discrimination (ISD) and HIV testing intervention, to a status-neutral intervention to increase HIV testing, PrEP, and ART Uptake (HPART) among young gay, bisexual, and other men who have sex with men in Ghanaian slums. Specific objectives include, Assessing intersectional stigma and options for HPART implementation, Adapting Lafiya to a status-neutral intervention to address intersectional stigma and increase HPART uptake among YGBMSM, Test acceptance, feasibility, appropriateness, and preliminary efficacy of Lafiya to address intersectional stigma and increase HIVST uptake., conditionsModule conditions: HIV Prevention and Care, designModule studyType: INTERVENTIONAL, phases: NA, designInfo allocation: RANDOMIZED, interventionModel: FACTORIAL, interventionModelDescription: intervention and waitlist control groups, primaryPurpose: PREVENTION, maskingInfo masking: NONE, maskingDescription: None (Open Label), enrollmentInfo count: 1193, type: ESTIMATED, armsInterventionsModule interventions name: LAFIYA, outcomesModule primaryOutcomes measure: Change in HIV testing., primaryOutcomes measure: Change in PrEP Adherence., primaryOutcomes measure: Change in ART Adherence, primaryOutcomes measure: Change in Treatment Self-Efficacy., secondaryOutcomes measure: Percentage change in HIV stigmatizing attitudes., secondaryOutcomes measure: Percentage change in reported sexual behavior stigma., secondaryOutcomes measure: Percentage change in gender nonconformity stigma, secondaryOutcomes measure: Percentage change in PrEP-related stigma, secondaryOutcomes measure: Neighborhood stigma, secondaryOutcomes measure: Mean change in the Basic Needs Satisfaction, secondaryOutcomes measure: Percentage of participants that reported healthcare climate stigma., secondaryOutcomes measure: Percentage of participants that reported Brief Resilience, secondaryOutcomes measure: Changes in Healthcare facility Intersectional stigma and discrimination., eligibilityModule sex: MALE, minimumAge: 18 Years, maximumAge: 25 Years, stdAges: ADULT, contactsLocationsModule locations facility: University of Ghana, city: Accra, country: Ghana, geoPoint lat: 5.55602, lon: -0.1969, hasResults: False
protocolSection identificationModule nctId: NCT06312501, orgStudyIdInfo id: 2021-0020 TELESAT, briefTitle: Remote Patient Monitoring for Patients With Heart Failure in France, acronym: TELESAT, statusModule overallStatus: COMPLETED, startDateStruct date: 2018-08-01, primaryCompletionDateStruct date: 2021-12-31, completionDateStruct date: 2022-12-31, studyFirstPostDateStruct date: 2024-03-15, lastUpdatePostDateStruct date: 2024-03-15, sponsorCollaboratorsModule leadSponsor name: Satelia, class: INDUSTRY, descriptionModule briefSummary: The goal of this multicenter observational longitudinal cohort study is to evaluate the ability of a Remote Patient Monitoring (RPM) program to prevent cardiac decompensation by detecting weak signals of decompensation early in patients with chronic heart failure in France.The main question it aims to answer is whether an RPM solution can provide the improvement in overall patient survivalParticipants will answer to questionnaires provided by the RPM solution for the follow-up of their condition.Researchers will compare the following cohorts to see if RPM can improve their condition:* Cohort 1: using RPM for follow-ups.* Cohort 2: conventional care and not using any devices and solutions for the follow-ups., conditionsModule conditions: Heart Failure, conditions: Patient Empowerment, conditions: Cardiac Failure, designModule studyType: OBSERVATIONAL, designInfo observationalModel: COHORT, timePerspective: RETROSPECTIVE, enrollmentInfo count: 20000, type: ACTUAL, armsInterventionsModule interventions name: Satelia®Cardio, interventions name: Conventional care, outcomesModule primaryOutcomes measure: Number of All Causes Deaths, secondaryOutcomes measure: Number of unplanned heart failure Hospitalization, secondaryOutcomes measure: Number of All Causes Deaths in elderly patients, secondaryOutcomes measure: Number of unplanned hospitalization for heart failure in elderly patients, eligibilityModule sex: ALL, minimumAge: 18 Years, stdAges: ADULT, stdAges: OLDER_ADULT, contactsLocationsModule locations facility: NP Medical, city: Bordeaux, zip: 33000, country: France, geoPoint lat: 44.84044, lon: -0.5805, hasResults: False
protocolSection identificationModule nctId: NCT06312488, orgStudyIdInfo id: 4097, briefTitle: Point of Care Evaluation of Fibrinolysis in Sepsis, acronym: POCEFIS, statusModule overallStatus: RECRUITING, startDateStruct date: 2024-01-22, primaryCompletionDateStruct date: 2025-03-31, completionDateStruct date: 2025-08-31, studyFirstPostDateStruct date: 2024-03-15, lastUpdatePostDateStruct date: 2024-03-15, sponsorCollaboratorsModule leadSponsor name: Policlinico Hospital, class: OTHER, descriptionModule briefSummary: Impaired fibrinolysis in septic patients is associated with worse outcome. The present study investigates fibrinolysis shutdown in septic patients, defined as prolonged ClotPro® TPA lysis time at 30 minutes. The TPA lysis time reference range is established in a cohort of healthy volunteers., conditionsModule conditions: Fibrinolytic Defect, conditions: Sepsis, conditions: Critical Illness, designModule studyType: INTERVENTIONAL, phases: NA, designInfo allocation: NON_RANDOMIZED, interventionModel: PARALLEL, primaryPurpose: DIAGNOSTIC, maskingInfo masking: NONE, enrollmentInfo count: 100, type: ESTIMATED, armsInterventionsModule interventions name: Clot Pro, outcomesModule primaryOutcomes measure: Prevalence of impaired fibrinolysis, secondaryOutcomes measure: Correlation between impaired fibrinolysis and changes in coagulation standard tests, secondaryOutcomes measure: Correlation between impaired fibrinolysis and inflammation markers, secondaryOutcomes measure: Correlation between impaired fibrinolysis and multiorgan failure, secondaryOutcomes measure: Correlation between impaired fibrinolysis and ICU lenght of stay, secondaryOutcomes measure: Correlation between impaired fibrinolysis and ICU mortality, otherOutcomes measure: Trend of fibrinolysis in the first ICU week with repeated ClotPro® tests, eligibilityModule sex: ALL, minimumAge: 18 Years, stdAges: ADULT, stdAges: OLDER_ADULT, contactsLocationsModule locations facility: Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, status: RECRUITING, city: Milan, state: MI, zip: 20100, country: Italy, contacts name: Mauro Panigada, MD, role: CONTACT, phone: 02 5503 3258, email: mauro.panigada@policlinico.mi.it, geoPoint lat: 45.46427, lon: 9.18951, hasResults: False
protocolSection identificationModule nctId: NCT06312462, orgStudyIdInfo id: PembaMoH, briefTitle: Health Education Model Led by Community Health Volunteers., statusModule overallStatus: ACTIVE_NOT_RECRUITING, startDateStruct date: 2024-01-01, primaryCompletionDateStruct date: 2025-02, completionDateStruct date: 2025-05, studyFirstPostDateStruct date: 2024-03-15, lastUpdatePostDateStruct date: 2024-03-15, sponsorCollaboratorsModule leadSponsor name: Pemba Ministry of Health Zanzibar, class: OTHER, descriptionModule briefSummary: The goal of this intervention study is to investigate the level of knowledge, attitudes, and behaviors of students on schistosomiasis in Pemba Island. It aims to test the effectiveness of establishing a widely applicable Community Health Volunteers model in the Zanzibar region and explore the feasibility of promoting this model in other areas of Africa. This study also aims to provide valuable insights and references for global schistosomiasis prevention and control efforts., conditionsModule conditions: Schistosomiasis, conditions: Health Education, designModule studyType: INTERVENTIONAL, phases: NA, designInfo allocation: RANDOMIZED, interventionModel: PARALLEL, interventionModelDescription: This model evaluates the effectiveness of schistosomiasis health education led by community health volunteers by training the volunteers on Pemba Island and having them conduct health education for local students. It also discusses the feasibility of promoting this model in Africa., primaryPurpose: HEALTH_SERVICES_RESEARCH, maskingInfo masking: NONE, enrollmentInfo count: 400, type: ESTIMATED, armsInterventionsModule interventions name: health education, outcomesModule primaryOutcomes measure: change in infection rate, primaryOutcomes measure: Change in Knowledge Level, primaryOutcomes measure: Attitudes Changes, primaryOutcomes measure: Behaviors Changes, secondaryOutcomes measure: Student satisfaction survey, eligibilityModule sex: ALL, minimumAge: 7 Years, maximumAge: 15 Years, stdAges: CHILD, contactsLocationsModule locations facility: Neglected tropical diseases in Pemba, city: Pemba, state: CharkChark, zip: P.O.BOX 98, country: Tanzania, hasResults: False
protocolSection identificationModule nctId: NCT06312449, orgStudyIdInfo id: 2211110001, briefTitle: Effect of Peanut Balls Used of the Second Stage of Labor, Pushing Perceptions, Fatigue and Birth Outcomes, statusModule overallStatus: COMPLETED, startDateStruct date: 2023-03-01, primaryCompletionDateStruct date: 2023-09-20, completionDateStruct date: 2023-09-23, studyFirstPostDateStruct date: 2024-03-15, lastUpdatePostDateStruct date: 2024-03-15, sponsorCollaboratorsModule leadSponsor name: Tung Yu-Ching, class: OTHER, collaborators name: Chang Gung Memorial Hospital, descriptionModule briefSummary: This study aims to explore the use of peanut balls during the second stage of labor. It compares three different positions: traditional lithotomy position, lateral position, and lateral position with peanut ball in terms of women's perceived pushing effort experiences, fatigue, and birth outcomes., conditionsModule conditions: Other, designModule studyType: INTERVENTIONAL, phases: NA, designInfo allocation: NON_RANDOMIZED, interventionModel: SEQUENTIAL, primaryPurpose: SUPPORTIVE_CARE, maskingInfo masking: NONE, enrollmentInfo count: 162, type: ACTUAL, armsInterventionsModule interventions name: The side-lying position with the peanut ball during the second stage of labor., interventions name: During the second stage, the patient is placed in a lateral position, outcomesModule primaryOutcomes measure: The duration of the second stage of labor of women who use side-lying with peanut balls., primaryOutcomes measure: The pushing time of women in the second stage of labor who use side-lying with peanut balls., primaryOutcomes measure: lateral position with peanut ball in terms of women's perceived pushing effort experiences., primaryOutcomes measure: Parturients using the side-lying position with a peanut ball for experience levels of fatigue., eligibilityModule sex: FEMALE, minimumAge: 20 Years, stdAges: ADULT, stdAges: OLDER_ADULT, contactsLocationsModule locations facility: Yu-Ching Tung, city: Taoyuan City, country: Taiwan, geoPoint lat: 24.95233, lon: 121.20193, hasResults: False
protocolSection identificationModule nctId: NCT06312436, orgStudyIdInfo id: AT-REBOA, briefTitle: The AT-REBOA Target Trial, acronym: AT-REBOA, statusModule overallStatus: ACTIVE_NOT_RECRUITING, startDateStruct date: 2019-01-01, primaryCompletionDateStruct date: 2023-10-01, completionDateStruct date: 2024-03, studyFirstPostDateStruct date: 2024-03-15, lastUpdatePostDateStruct date: 2024-03-15, sponsorCollaboratorsModule leadSponsor name: Medical University of Graz, class: OTHER, descriptionModule briefSummary: Temporary aortic occlusion can limit haemorrhage, can help to maintain perfusion to the heart and brain, and may be associated with improved survival. Resuscitative Endovascular Balloon Occlusion of the Aorta (REBOA) potentially provides a relatively quick means of achieving this temporary control.In the past years, studies have tried to evaluate the benefit for this method with conflicting results. The previous UK-REBOA trial has not found any benefit in the intervention group and has even hinted at possible harm caused by the intervention. A major limitation of this study is the low number of interventions performed in participating trauma centres and the associated potentially insufficient experience with REBOA.The aim of this study is to evaluate the effectiveness of REBOA in a setting with already experienced providers., conditionsModule conditions: Hemorrhage, conditions: Shock, Traumatic, conditions: Cardiac Arrest Due to Trauma, conditions: Polytrauma, designModule studyType: OBSERVATIONAL, designInfo observationalModel: CASE_CONTROL, timePerspective: RETROSPECTIVE, enrollmentInfo count: 44, type: ACTUAL, armsInterventionsModule interventions name: Resuscitative Endovascular Balloon Occlusion of the Aorta (REBOA), outcomesModule primaryOutcomes measure: 30-day in-hospital mortality, secondaryOutcomes measure: 3-hour mortality, secondaryOutcomes measure: 6-hour mortality, secondaryOutcomes measure: 24-hour mortality, secondaryOutcomes measure: 90-day mortality, secondaryOutcomes measure: Intensive Care Unit length of stay, secondaryOutcomes measure: Hospital length of stay, secondaryOutcomes measure: Blood product use, secondaryOutcomes measure: Use of whole body computed tomography, secondaryOutcomes measure: damage control procedure performed, secondaryOutcomes measure: Time to damage control procedure, secondaryOutcomes measure: Rate of complications, secondaryOutcomes measure: Cause of death, eligibilityModule sex: ALL, minimumAge: 16 Years, stdAges: CHILD, stdAges: ADULT, stdAges: OLDER_ADULT, contactsLocationsModule locations facility: University Medical Centre Graz, city: Graz, state: Styria, zip: 8036, country: Austria, geoPoint lat: 47.06667, lon: 15.45, locations facility: Center for Medical Data Science, city: Vienna, zip: 1090, country: Austria, geoPoint lat: 48.20849, lon: 16.37208, hasResults: False
protocolSection identificationModule nctId: NCT06312423, orgStudyIdInfo id: ECDA000/02, briefTitle: Safety and Pharmacokinetics of IMT504, an Immunomodulator and Tissue Repair Inducer, acronym: ECDA000/02, statusModule overallStatus: RECRUITING, startDateStruct date: 2024-02-23, primaryCompletionDateStruct date: 2024-08-30, completionDateStruct date: 2024-12-30, studyFirstPostDateStruct date: 2024-03-15, lastUpdatePostDateStruct date: 2024-03-15, sponsorCollaboratorsModule leadSponsor name: Ministry of Public Health of the Province of La Rioja, class: OTHER_GOV, collaborators name: Immunalgia Therapeutics S.A., descriptionModule briefSummary: Phase 1 open-label dose-escalation study to evaluate the safety and pharmacokinetics of IMT504 Phosphorothioate Oligonucleotide, an immunomodulator and tissue repair inducer, in healthy volunteers., conditionsModule conditions: Immune System, designModule studyType: INTERVENTIONAL, phases: PHASE1, designInfo allocation: NON_RANDOMIZED, interventionModel: SEQUENTIAL, interventionModelDescription: A total of 12 healthy adult volunteers of both sexes will be included, who will be progressively incorporated into 3 groups of 4 volunteers each. All volunteers will be evaluated at a research site authorized by the Regulatory Authority (ANMAT) to conduct phase 1 studies., primaryPurpose: TREATMENT, maskingInfo masking: NONE, enrollmentInfo count: 12, type: ESTIMATED, armsInterventionsModule interventions name: Oligonucleotides, Phosphorothioate, outcomesModule primaryOutcomes measure: Safety: Local and systemic reaction after administration of each dose of the investigational drug, primaryOutcomes measure: Safety: Serious adverse event, primaryOutcomes measure: Safety: Variations in the Laboratory results, primaryOutcomes measure: Pharmacokinetics: IMT504 level in Serum, primaryOutcomes measure: Pharmacokinetics: IMT504 level in Serum, primaryOutcomes measure: Pharmacokinetics: IMT504 level in Serum, primaryOutcomes measure: Pharmacokinetics: IMT504 level in Serum, primaryOutcomes measure: Pharmacokinetics: IMT504 level in Serum, secondaryOutcomes measure: Pharmacodynamics: Interleukin - 35, eligibilityModule sex: ALL, minimumAge: 18 Years, stdAges: ADULT, stdAges: OLDER_ADULT, contactsLocationsModule locations facility: CENTRO DE INVESTIGACIÓN PARA ESTUDIOS DE FARMACOLOGÍA CLÍNICA DE FASE1 EN POBLACIÓN ADULTA y DE BIOEQUIVALENCIA. Sanatorio Nuestra Señora del Pilar, status: RECRUITING, city: Buenos Aires, zip: 1702, country: Argentina, contacts name: Eduardo Pirotzky, Doctor, role: CONTACT, phone: 541144696700, email: epirotzky@yahoo.com, geoPoint lat: -34.61315, lon: -58.37723, hasResults: False
protocolSection identificationModule nctId: NCT06312397, orgStudyIdInfo id: MU-HF-BVD-01, briefTitle: The Effect on Back Pain and Fatigue Level of Acupressure, statusModule overallStatus: RECRUITING, startDateStruct date: 2024-03-04, primaryCompletionDateStruct date: 2024-07-30, completionDateStruct date: 2024-08-30, studyFirstPostDateStruct date: 2024-03-15, lastUpdatePostDateStruct date: 2024-03-15, sponsorCollaboratorsModule leadSponsor name: Mersin University, class: OTHER, descriptionModule briefSummary: This research was conducted with the aim of determining the effect of acupressure on the level of back pain and fatigue after coronary angiography., conditionsModule conditions: Coronary Angiography, designModule studyType: INTERVENTIONAL, phases: NA, designInfo allocation: RANDOMIZED, interventionModel: PARALLEL, interventionModelDescription: Three groups ( acupressure group, sham acupressure group and control group), primaryPurpose: SUPPORTIVE_CARE, maskingInfo masking: SINGLE, maskingDescription: Patients in the acupressure and sham acupressure groups were blinded as to which groups they were in., whoMasked: PARTICIPANT, enrollmentInfo count: 120, type: ESTIMATED, armsInterventionsModule interventions name: Acupressure, interventions name: Sham acupressure, outcomesModule primaryOutcomes measure: Visual Analog Scale for Pain, primaryOutcomes measure: Visual Analog Scale for Fatigue, eligibilityModule sex: ALL, minimumAge: 18 Years, maximumAge: 80 Years, stdAges: ADULT, stdAges: OLDER_ADULT, contactsLocationsModule locations facility: Birgül VURAL DOĞRU, status: RECRUITING, city: Mersin, zip: 33110, country: Turkey, contacts name: Birgül VURAL DOĞRU, Associate Professor, role: CONTACT, phone: 03243610001, email: bvuraldogru@gmail.com, geoPoint lat: 36.79526, lon: 34.61792, hasResults: False
protocolSection identificationModule nctId: NCT06312384, orgStudyIdInfo id: A04080622, briefTitle: The Influence of 3D Surgical Template on the Contour of Bone Augmentation, in Patient With Labial Alveolar Ridge Defect and Simultaneous Implantation, statusModule overallStatus: ACTIVE_NOT_RECRUITING, startDateStruct date: 2022-07-01, primaryCompletionDateStruct date: 2024-05, completionDateStruct date: 2024-06, studyFirstPostDateStruct date: 2024-03-15, lastUpdatePostDateStruct date: 2024-03-15, sponsorCollaboratorsModule leadSponsor name: Mansoura University, class: OTHER, descriptionModule briefSummary: Evaluate the impact of using 3D surgical template with guided bone regeneration technique on the contour of bone augmentation in patients with horizontal labial ridge defect and simultaneous implantation., conditionsModule conditions: Bone Deformity, designModule studyType: INTERVENTIONAL, phases: PHASE3, designInfo allocation: RANDOMIZED, interventionModel: PARALLEL, interventionModelDescription: Group 1 \[Control group\]:The defected site will be grafted with sticky bone (particulate bone substitute mixed with injectable platelet-rich fibrin (i-PRF)) and will be covered with collagen membrane will be applied \[conventional GTR\].Group 2 \[Study group\]:The defected site will be grafted with sticky bone (particulate bone substitute mixed with injectable platelet-rich fibrin (i-PRF)) and will be covered with collagen membrane will be applied, in this group 3D surgical template will be applied., primaryPurpose: TREATMENT, maskingInfo masking: SINGLE, maskingDescription: each patient will be couded and only the princeiple investigator is the only person how know the type of intervantion, whoMasked: OUTCOMES_ASSESSOR, enrollmentInfo count: 20, type: ESTIMATED, armsInterventionsModule interventions name: 3D Surgical Template on the Contour of Bone Augmentation, in Patient With Labial Alveolar Ridge Defect and Simultaneous Implantation, interventions name: conventional guided bone regeneration,in Patient With Labial Alveolar Ridge Defect and Simultaneous Implantation, outcomesModule primaryOutcomes measure: Change in Radiographic assessment for all patients underwent Cone beam computed tomography (CBCT) scans, eligibilityModule sex: ALL, minimumAge: 18 Years, maximumAge: 65 Years, stdAges: ADULT, stdAges: OLDER_ADULT, contactsLocationsModule locations facility: Faculty of Dentistry-Mansoura University, city: Mansoura, zip: 35516, country: Egypt, geoPoint lat: 31.03637, lon: 31.38069, hasResults: False
protocolSection identificationModule nctId: NCT06312371, orgStudyIdInfo id: Feeding Hesitancy, briefTitle: Intermittent Oro-esophageal Tube on Feeding Hesitancy in Stroke Patients, statusModule overallStatus: NOT_YET_RECRUITING, startDateStruct date: 2024-03, primaryCompletionDateStruct date: 2024-12, completionDateStruct date: 2024-12, studyFirstPostDateStruct date: 2024-03-15, lastUpdatePostDateStruct date: 2024-03-15, sponsorCollaboratorsModule leadSponsor name: Muhammad, class: OTHER, descriptionModule briefSummary: The aim of this clinical trial is to compare Feeding Hesitancy of ischemic stroke patients who receive enteral nutrition support through either Intermittent Oro-esophageal Tube or Nasogastric Tube. Patients will be randomly assigned to either an observation group or a control group, with both groups receiving routine rehabilitation treatment. The observation group will receive enteral nutrition support through Intermittent Oro-esophageal Tube, while the control group will receive it through Nasogastric Tube. Researchers will then compare Feeding Hesitancy of the two groups., conditionsModule conditions: Dysphagia, designModule studyType: INTERVENTIONAL, phases: NA, designInfo allocation: RANDOMIZED, interventionModel: PARALLEL, primaryPurpose: SUPPORTIVE_CARE, maskingInfo masking: SINGLE, whoMasked: OUTCOMES_ASSESSOR, enrollmentInfo count: 80, type: ESTIMATED, armsInterventionsModule interventions name: Intermittent Oro-esophageal Tube Feeding, interventions name: Nasogastric Tube Feeding, outcomesModule primaryOutcomes measure: Swallowing Quality of Life questionnaire, eligibilityModule sex: ALL, minimumAge: 18 Years, maximumAge: 80 Years, stdAges: ADULT, stdAges: OLDER_ADULT, contactsLocationsModule, hasResults: False